Moderna to transform Massachusetts site into industrial technology centre
The expansion will support a 50% increase in production of biotech's COVID-19 vaccine at its manufacturing site
mRNA pioneer Moderna has announced plans to expand its Moderna Technology Center (MTC) in Norwood, Massachusetts, which will see the company more than double the space to transform the facility to an industrial technology centre.
Specifically, the company will increase production and lab space from approximately 300,000 sq. ft to approximately 650,000 sq. ft through renovating existing space and acquiring a 240,000 sq. foot building located on the same campus for expansion of its commercial and clinical activities.
According to Moderna CEO, Stéphane Bancel, the expansion of the manufacturing facility will enable the company to continue to optimize its mRNA medicines and vaccines and "explore new pharmaceutical delivery forms such as prefilled syringes and lyophilized products."
This expansion also includes an increase in Moderna’s technical development capacity and preclinical production capability with the goal of producing thousands of preclinical samples per month for research and development. The expanded facility will also help facilitate the company’s increased focus and investment in technical capabilities such as expansion of shelf-life stability.
The investment will support a 50% increase in production of Moderna's COVID-19 vaccine at its manufacturing site, which is expected to ramp up in late 2021 and early 2022.
Last week, the company announced an investment at its owned and partnered manufacturing facilities that it expects will increase 2022 global capacity to up to 3 billion doses of its COVID-19 vaccine, depending upon the mix between the authorized Moderna COVID-19 Vaccine at the 100 μg dose level and potentially lower doses of the company’s variant booster candidates and pediatric vaccines, if authorized.
The company also raised its 2021 manufacturing supply forecast to between 800 million to 1 billion doses.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance